Open Trial of Cyclosporine in Patients with Severe Active Crohn's Disease Refractory to Conventional Therapy
Fifteen patients with severe active Crohn's disease, refractory to conventional therapy, were given a 16 week course of cyclosporine ar an initial oral daily dose of 10 mg/kg, adjusted to maintain cyclosporine scrum trough levels between 100 and 200 ng/ml. Five patients withdrew early because o...
Saved in:
Main Authors: | Kevork M. Peltekian, C. Noel Williams, Allan S. MacDonald, Peter D. Roy, Elizabeth Czolpinska |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1988-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1988/970381 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Cyclosporine in Crohn's Disease
by: CN Williams
Published: (1990-01-01) -
Clinical experience with cyclosporine eye drops for severe dry eye
by: O.I. Lebedev, et al.
Published: (2019-04-01) -
Improving Access to Transient Elastography in Canada Will Need More Than Evidence-Based Guidelines and Technical Health Assessment
by: Kevork M Peltekian
Published: (2015-01-01) -
Refractory Crohn’s Disease of the Vulva Treated with Infliximab: A Case Report
by: Sapna Makhija, et al.
Published: (2007-01-01) -
Clinical efficacy of 0.1% cyclosporine A in dry eye patients with inadequate responses to 0.05% cyclosporine A: a switching, prospective, open-label, multicenter study
by: Sook Hyun Yoon, et al.
Published: (2025-01-01)